Prostatic Obstruction Investigation Team Multicenter Study
NCT ID: NCT03394651
Last Updated: 2018-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
11500 participants
OBSERVATIONAL
2018-04-01
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Benign Prostatic Hyperplasia on Bladder Function
NCT03098147
Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men
NCT03043222
Prostatic Urethral Lift in Subject With Acute Urinary Retention
NCT03194737
Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH
NCT05440981
Botulinum Toxin Injection for the Management of BPH
NCT00451191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral medication group
Patients in this group will receive oral medications to treat lower urinary tract symptoms
Oral medications to treat lower urinary tract symptoms
Patients in this group will receive oral medication(s) depending on doctors' prescriptions.
Surgical treatment group
Patients in this group receive minimal invasive transurethral prostate procedures.
Minimal invasive transurethral prostate procedures
Patients in this group will receive surgical treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral medications to treat lower urinary tract symptoms
Patients in this group will receive oral medication(s) depending on doctors' prescriptions.
Minimal invasive transurethral prostate procedures
Patients in this group will receive surgical treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The presence of lower urinary tract symptoms, i.e. frequency, urgency, urge incontinence, dysuria, post-micturition dribble, etc.
3. All participants have signed the informed consent form.
4. Clinical data comes from 23 selected hospitals spread across China.
Exclusion Criteria
2. Diagnosis or suspicion of renal, ureteral, bladder, prostate, urethral or pelvic tumor.
3. Known neurogenic or congenital lower urinary tract dysfunction.
4. Known urinary tract, prostate or pelvic surgical history.
5. Existence of anatomical abnormalities of the urinary tract (e.g. diverticulum of the bladder or urethra, ectopic ureteral orifice etc.).
6. The presence of acute conditions, such as, urinary tract infection, fever, heart failure etc.
7. Patients with poor compliance or cognitive competence.
45 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Hospital
OTHER_GOV
Zhongda Hospital
OTHER
RenJi Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
The Second Hospital of Nanjing Medical University
OTHER
Shanghai Changzheng Hospital
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
First Affiliated Hospital of Suzhou Medical College
OTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Zhujiang Hospital
OTHER
Zhejiang University
OTHER
Shanghai Zhongshan Hospital
OTHER
Xinqiao Hospital of Chongqing
OTHER
Zhejiang Provincial People's Hospital
OTHER
Huashan Hospital
OTHER
Southwest Hospital, China
OTHER
First Affiliated Hospital of Fujian Medical University
OTHER
The First Affiliated Hospital of Beijing University
UNKNOWN
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
OTHER
Tianjin Medical University Second Hospital
OTHER
The Third Affiliated Hospital of Beijing University
UNKNOWN
Jiangsu Provincial People's Hospital
OTHER
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yinghao Sun
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yinghao Sun, MD, PhD
Role: STUDY_CHAIR
Changhai Hospital
Wei Xue, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
RenJi Hospital
Qi-Xiang Song, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Changhai Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changhai Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Song QX, Zhang Y, Ye X, Xue W, Xu C, Xu J, Abrams P, Sun Y; Prostatic Obstruction Investigation Team (POInT). Current status and progression of lower urinary tract symptoms in Chinese male patients: the protocol and rationale for a nationwide, hospital-based, prospective, multicentre study. BMJ Open. 2019 Sep 27;9(9):e028378. doi: 10.1136/bmjopen-2018-028378.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POINT-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.